Form 8-K Privia Health Group, For: Feb 27

Go back to Form 8-K Privia Health Group, For: Feb 27

Privia Health Group Inc (PRVA) PT Lowered to $28 at Truist Securities

February 29, 2024 5:50 AM EST

Truist Securities analyst Jailendra Singh lowered the price target on Privia Health Group Inc (NASDAQ: PRVA) to $28.00 (from $32.00) while maintaining a Buy rating.

The analyst comments "We had a post quarterly conference call with PRVA management to discuss its 4Q23 results, 2024... More

JPMorgan Positive on Privia Health Group Inc (PRVA) Following Earnings, Management Call

February 27, 2024 12:09 PM EST

JPMorgan analyst Lisa C. Gill reiterated an Overweight rating and $20.00 price target on Privia Health Group Inc (NASDAQ: PRVA)

The analyst comments "We are positive on PRVA as the companys notably more conservative and contrarian approach to capitated risk is driving greater financial... More